- Home
- CVKD vs ALBT Comparison
CVKD vs ALBT Comparison
Compare CVKD & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- ALBT
- Stock Information
- Founded
- CVKD 2022
- ALBT 2014
- Country
- CVKD United States
- ALBT United States
- Employees
- CVKD N/A
- ALBT N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVKD Health Care
- ALBT Health Care
- Exchange
- CVKD Nasdaq
- ALBT Nasdaq
- Market Cap
- CVKD 17.1M
- ALBT 2.9M
- IPO Year
- CVKD 2023
- ALBT N/A
- Fundamental
- Price
- CVKD $15.24
- ALBT $0.20
- Analyst Decision
- CVKD Strong Buy
- ALBT
- Analyst Count
- CVKD 2
- ALBT 0
- Target Price
- CVKD $52.50
- ALBT N/A
- AVG Volume (30 Days)
- CVKD 59.6K
- ALBT 633.7K
- Earning Date
- CVKD 11-08-2024
- ALBT 11-12-2024
- Dividend Yield
- CVKD N/A
- ALBT N/A
- EPS Growth
- CVKD N/A
- ALBT N/A
- EPS
- CVKD N/A
- ALBT N/A
- Revenue
- CVKD N/A
- ALBT N/A
- Revenue This Year
- CVKD N/A
- ALBT N/A
- Revenue Next Year
- CVKD N/A
- ALBT N/A
- P/E Ratio
- CVKD N/A
- ALBT N/A
- Revenue Growth
- CVKD N/A
- ALBT N/A
- 52 Week Low
- CVKD $5.40
- ALBT $0.16
- 52 Week High
- CVKD $32.55
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- CVKD 60.90
- ALBT 43.14
- Support Level
- CVKD $11.19
- ALBT $0.16
- Resistance Level
- CVKD $15.93
- ALBT $0.22
- Average True Range (ATR)
- CVKD 1.36
- ALBT 0.03
- MACD
- CVKD 0.23
- ALBT 0.00
- Stochastic Oscillator
- CVKD 61.01
- ALBT 27.54
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.